STTK

STTK

USD

Shattuck Labs Inc. Common Stock

$0.763-0.037 (-4.600%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$0.800

高値

$0.835

安値

$0.757

出来高

0.00M

企業ファンダメンタルズ

時価総額

38.5M

業種

バイオテクノロジー

United States

取引統計

平均出来高

0.22M

取引所

NMS

通貨

USD

52週レンジ

安値 $0.692現在値 $0.763高値 $11.76

AI分析レポート

最終更新: 2025年4月13日
AIによる生成データソース: Yahoo Finance, Bloomberg, SEC

[STTK: Shattuck Labs Inc. Common Stock]: Recent Buzz, Price Moves, and a Peek at What's Next

Stock Symbol: STTK Generate Date: 2025-04-13 08:45:18

Let's dive into what's been happening with Shattuck Labs (STTK). For folks who aren't glued to financial news all day, we'll break down the recent updates and what they might mean for this stock.

Recent News Buzz: A Mix of Steady and Sparky

What's the general feeling around Shattuck Labs lately? It's a bit of a mixed bag, but with a recent positive jolt.

  • The Steady Drumbeat: We've seen a few analyst reports from Needham and HC Wainwright basically saying "Hold" on STTK. Think of this like a shrug – not bad, not great, just "meh, keep watching." Also, Shattuck announced they'll be at a healthcare conference soon. This is pretty standard stuff for biotech companies – getting their name out there. They also dropped their financial results for last year and some updates on their drug development, which is again, part of the routine.

  • The Spark: Here's where things get a bit more interesting. Leerink Partners, a bigger name in the analyst world, just started covering Shattuck and gave them an "Outperform" rating with a $4 price target. That's a pretty strong thumbs up and suggests they see some real potential here. This is definitely the most positive news in the bunch.

So, the vibe? Mostly quiet, business-as-usual, until this recent "Outperform" rating popped up. That analyst upgrade is the freshest and most impactful news right now, likely turning some heads.

Price Check: A Wild Ride Lately

Let's look at the stock price itself. Over the last month or so, it's been anything but boring.

  • The Rollercoaster: If you glance at the price chart, it's been a bit of a wild ride. Back in January and February, the price was mostly hovering around the $1.10 to $1.30 range. Then, BAM! Late February saw a massive spike, almost hitting $2. But what goes up fast can come down fast, and it did. March was mostly a slide back down, settling around the $1.20 mark, then drifting lower again. Then, out of nowhere on April 7th, another huge jump – from under $0.80 to over $1.40 in a single day! Since then, it's pulled back again and seems to be hanging around the $0.90 level currently. Lots of ups and downs recently.

  • Current Price vs. Predictions: Right now, STTK is around $0.90. The AI prediction model thinks it might nudge up a little today and tomorrow, and then see a slightly bigger jump the day after. Nothing huge predicted, but a generally upward direction in the very short term.

In short: The price action has been very volatile recently. Big spikes followed by pullbacks. Currently, it's lower than the recent peak, but the AI is hinting at some minor upward movement soon.

Outlook & Ideas: What Could This Mean?

Putting it all together, what's the potential story here, and what could you consider if you're watching STTK?

  • Near-Term Lean: Given the recent positive analyst upgrade from Leerink, the AI's short-term price predictions nudging upwards, and the fact that the stock has pulled back from its recent spike, the situation might be leaning slightly towards a potential 'buy' or 'accumulate' opportunity for the very short term. However, and this is important, the stock is clearly volatile, so caution is key.

  • Potential Entry Consideration: If you were thinking about getting in, the current price area around $0.90 could be interesting. It's near where the stock seems to have stabilized after the recent price swings. Plus, the AI predictions suggest it might not drop much further in the immediate future. But remember, predictions aren't guarantees.

  • Potential Exit/Stop-Loss Ideas: Because of the volatility, having a plan to manage risk is crucial. A stop-loss around $0.85 could be considered. This is just below the recent lows and might help limit losses if the price decides to drop again. For taking profits, if the stock does move up as the AI predicts and the Leerink analyst suggests, a take-profit level around $1.04 (as suggested in the recommendation data) could be a short-term target. This is just an idea, and you'd need to watch how the stock actually behaves.

  • Company Context Reminder: Shattuck Labs is in biotech. This sector is known for being risky but with potential for big rewards if their drugs pan out. News about drug development, clinical trials, and regulatory approvals are major drivers for these stocks. Keep an eye on any updates from Shattuck on their drug pipeline.

Important Note: This is just an analysis based on the data we have right now. The stock market is unpredictable, especially with smaller biotech companies like Shattuck Labs. Things can change fast. This is not financial advice. Do your own thorough research and consider talking to a financial professional before making any decisions about STTK or any other stock. Investing in the stock market involves risk, and you could lose money.

関連ニュース

GlobeNewswire

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

AUSTIN, TX and DURHAM, NC, April 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF)

もっと見る
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
Analyst Upgrades

Needham Reiterates Hold on Shattuck Labsto Hold

Needham analyst Gil Blum reiterates Shattuck Labs from Hold to Hold.

もっと見る
Needham Reiterates Hold on Shattuck Labsto Hold
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Shattuck Labsto Neutral

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs from Neutral to Neutral.

もっと見る
HC Wainwright & Co. Reiterates Neutral on Shattuck Labsto Neutral
GlobeNewswire

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

– Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn's and Colitis Organization in Inflammatory Bowel Diseases 2025 (ECCO) for SL-325, a potentially first-in-class blocking antibody

もっと見る
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
Analyst Upgrades

Leerink Partners Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4

Leerink Partners analyst Faisal Khurshid initiates coverage on Shattuck Labs with a Outperform rating and announces Price Target of $4.

もっと見る
Leerink Partners Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4

AI予測Beta

AI推奨

強気

更新日時: 2025年4月28日 15:56

弱気中立強気

63.3% 信頼度

リスクと取引

リスクレベル4/5
高リスク
適しているのは
バリューアグレッシブ
取引ガイド

エントリーポイント

$0.79

利確

$0.84

損切り

$0.72

主要因子

DMIは弱気トレンドを示しており (ADX:10.0、+DI:21.9、-DI:23.6)、注意が必要です
現在の価格はサポートレベル(0.79ドル)に非常に接近しており、強力な買い機会を示唆しています
出来高は平均(3,658)の2.5倍で、 significant buying interest(大幅な買い意欲)を示しています
MACD 0.0010はシグナルライン0.0002の上にあり、強気クロスオーバーを示しています

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。